Form 4: Amedisys Inc. Chief Accounting Officer Reports Changes in Beneficial Ownership

Allyson Guidroz, Chief Accounting Officer of Amedisys Inc., reports acquisition and disposal of common stock and restricted stock units (RSUs).

Summary

• On February 16, 2025, Allyson Guidroz, Chief Accounting Officer of Amedisys Inc., reported changes in beneficial ownership of the company's stock.
• Guidroz acquired 2,160 shares of common stock through the award of time-based RSUs at a price of $0.
• These RSUs will vest 25% on each of February 16, 2026 and February 16, 2027 and 50% on February 16, 2028, contingent upon continuous employment.
• Guidroz also disposed of 254 shares of common stock at a price of $92.6.
• Following these transactions, Guidroz directly owns 10,802 shares of common stock and indirectly owns 1.5 shares through a 401(k) plan as of December 31, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard SEC filing detailing transactions. The RSU grant is a positive sign, but the sale of shares is slightly negative, balancing out the overall sentiment.

Positives

• The acquisition of 2,160 shares through RSUs indicates confidence in the company's future performance, as the vesting is tied to continued employment.

Negatives

• The disposal of 254 shares could be interpreted negatively, although the quantity is small relative to the total holdings.

Risks

• The vesting of RSUs is contingent upon continuous employment, creating a risk of forfeiture if employment is terminated before the vesting dates.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule of the RSUs implies a multi-year commitment from the reporting person.

Industry Context

This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It's common for executives to receive stock-based compensation and periodically adjust their holdings.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their executives.
• The vesting schedule of the RSUs is typical for executive compensation packages, aligning management's interests with long-term shareholder value.
• Comparing the size and frequency of insider transactions with those of peers like LHC Group or Encompass Health can provide insights into relative management sentiment.

Stakeholder Impact

• Shareholders may be interested in the insider's transactions as an indicator of management's confidence in the company.
• Employees may view the RSU grants as a positive sign of the company's commitment to its employees.

Key Dates

Keywords

Amedisys, Guidroz, Beneficial Ownership, Form 4, RSUs, Common Stock, Insider Trading, SEC Filing